Back to directory
Investor
Lumira Ventures
Toronto, ON, Canada
The 50 · Multi-stage · Life Sciences
Leading North American healthcare VC building transformative biotechnology and medical device companies. Multi-stage investors identifying best-in-class in overlooked geographies. Cancer, cardiovascular, CNS, I&I, autoimmune.
- Type
- The 50
- Stage
- Multi-stage
- AUM
- US$500M
- Address
- 141 Adelaide Street, Suite 770, Toronto, ON M5H 3L5
- Other offices
- Vancouver · Montreal · Boston
- Source
- The 50: Canadian VC Ecosystem Guide 2026
Investment thesis
Leading North American healthcare VC building transformative biotechnology and medical device companies. Multi-stage investors identifying best-in-class in overlooked geographies. Cancer, cardiovascular, CNS, I&I, autoimmune.
What makes them unique
Market-leading performance: distributed returns in 19 of past 20 years. Six exits exceeding $1B in past six years. Deep domain expertise enabling thematic research.
Team
- 7 senior partners, 10 investment professionals, hundreds of years experience
Select portfolio
HistoSonics (2025 NVCA Startup Innovator, Fast Company #1)COURenGeneTransposon